🇺🇸 FDA

Company profile · Sponsor

PDS

PDS Biotechnology Corp

PDSB · NYSE biotech PRINCETON, NJ, USA
Pipeline
3
Drugs
0
Patents
8

Quick answer

PDS (PDSB) is a biotech company. headquartered in PRINCETON, NJ, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker PDSB
Exchange NYSE
Company type biotech
Headquarters PRINCETON, NJ, USA
SEC CIK 0001472091

Pipeline (3)

Search pipeline →

  1. Combination Treatment of PDS0101 and Pembrolizumab

    PDS

    Recurrent Head and Neck Cancer

    phase 3 other active

    1 trial

  2. Pembrolizumab (KEYTRUDA®) and PDS0101

    PDS

    Metastatic Head and Neck Cancer

    phase 2 other completed

    1 trial

  3. R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7

    PDS

    High-risk HPV Infection and Biopsy-proven CIN1

    phase 1 mab completed

    1 trial

Patents (8)

Search patents →

  1. US 11911359

    Stimulation of an immune response by cationic lipids

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11911465

    Vaccine compositions and methods of use

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11904015

    Vaccine compositions and methods of use

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11801257

    Stimulation of an immune response by enantiomers of cationic lipids

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11638753

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11612652

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10702541

    Stimulation of an immune response by enantiomers of cationic lipids

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is PDS?

PDS (PDSB) is a biotech company. headquartered in PRINCETON, NJ, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does PDS sponsor?

We track 3 ClinicalTrials.gov-linked programs for PDS, including Combination Treatment of PDS0101 and Pembrolizumab and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does PDS company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.